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Consequences of COVID-19 




A pandemic is an epidemic that spreads globally. Coronavirus disease 2019 
(COVID-19) caused a major pandemic that affected human health and activities 
around the world since the beginning of 2020 and became a major international 
emergency. Through multiple paths, COVID-19 pandemic influenced life at 
individual, familial, societal, and environmental levels and led to a global eco-
nomic recession. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
is the virus responsible for the disease. It invades the target cells by binding to 
angiotensin-converting enzyme 2 (ACE2). Endocrine and metabolic systems can be 
implicated in COVID-19 infection. Subjects with several comorbidities (e.g., hyper-
tension, diabetes, and obesity) are more likely to be infected and are at a higher 
risk for complications and death from COVID-19. Wearing mask, social distancing, 
home confinement, and isolation have been recommended and implemented in 
several countries to curb the spread of the outbreak. Vaccination remains the best 
protective measure. Different vaccines are now available and have been used. The 
worldwide impact of COVID-19 pandemic may last several years.
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1. Introduction
A pandemic is an epidemic that spreads globally, crosses international  
boundaries, and affects large number of people (Figure 1) [1, 2].
Through multiple mechanisms (e.g., infection and confinement/isolation), 
pandemics can influence life at individual, familial, societal, and environmental 
levels [3].
COVID-19 pandemic became a global health and economic crisis of the 21st 
century, representing one of the most profound medical, societal, and economic 
challenges in modern times [4–7]. Endocrine and metabolic systems can be 
involved in COVID-19 infection [8–48]. Diabetes and obesity negatively impact 
immune system and increase the risk of infection and morbidity/mortality due to 
COVID-19 [8–12, 14, 23–25, 31, 33–37].
Multiple COVID-19 vaccines are now available and have been used world-
wide [49–53].
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2. Pandemics
2.1 History of pandemics
Numerous pandemics have occurred throughout the history of mankind, the 
most recent being the COVID-19 pandemic [1, 2, 4–6].
Important pandemics that occurred over the last 1,500 years are reported 
in Table 1 (non-exhaustive list). The deadliest pandemics were the Plague of 
Justinian, the Black Death, and the Spanish Flu.
2.2 Consequences of pandemics
Through multiple paths (e.g., infection and confinement/isolation), pandemics 
can influence life at individual, familial, societal, and environmental levels [3].
At the individual level, there are health consequences (e.g., infection caused by 
the pathogen, metabolic diseases, mental disorders, impact on pre-existing condi-
tions, and eventually death), financial challenges (mainly due to unemployment), 
and educational consequences (due to remote learning).
At the familial level, the prolonged presence of parents and children at home can 
promote domestic violence.
At the societal level, the limitation of social life and activities will have major eco-
nomic consequences for several businesses (e.g., agriculture, restaurant, hotel, store, 
airline, cruise, convention, concert, sport event, museum, movie, and theater).
Figure 1. 
Pandemics affect large number of people in multiple countries.
Pandemic Name Pathogen Vector Date Mortality
Plague of Justinian Yersinia pestis Fleas 541–750 Up to 100,000,000
Black Death Yersinia pestis Fleas 1347–1351 Up to 200,000,000
Spanish Flu H1N1 virus Avian 1918–1919 Up to 100,000,000
Asian Flu H2N2 virus Avian 1957–1958 Up to 4,000,000
Hong Kong Flu H3N2 virus Avian 1968–1969 Up to 4,000,000
Swine Flu H1N1 virus Pigs 2009–2010 Up to 250,000
COVID-19 SARS-CoV-2 Unknown 2019-present At least 4,362,000*
*As of August 17, 2021.
Table 1. 
Important pandemics over the last 1,500 years (non-exhaustive list).
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At the environmental level, the confinement may have some health benefits, 
at least for short term, due to a reduction in air pollution mainly secondary to the 
decrease in circulating cars and flying planes. This can also positively impact the life 
of animals and plants.
3. COVID-19 pandemic
3.1 Virus
In January 2020, Chinese authorities announced the isolation of a new type of 
coronavirus, SARS-CoV-2, following the occurrence in December 2019 of several 
pneumonia cases of unknown etiology. On March 11, 2020, the World Health 
Organization (WHO) declared COVID-19 a pandemic.
COVID-19 is caused by one of the coronaviruses in the family of Coronaviridae. 
The virus belongs to genera Betacoronavirus and is the seventh coronavirus 
known to cause human diseases. It is a spherical or pleomorphic enveloped, non-
segmented, single-stranded, positive-sense RNA virus. The genome of the virus 
is composed of 29,903 nucleotides. The virus is made up of four main structural 
proteins: spike (S), membrane (M), envelope (E), and nucleocapsid (N) proteins 
(Figure 2) [4–6, 14, 25, 29, 38, 54, 55].
SARS-CoV-2 evolves over time and like other viruses is subject to mutations. 
The mutated virus is referred to as a variant of the original virus. Several variants 
of SARS-CoV-2 have been reported (e.g., Alpha, Beta, Delta, Epsilon, Eta, Gamma, 
Iota, Kappa, Lambda, Theta, and Zeta). They were initially detected in countries 
like the United Kingdom (UK), South Africa, Brazil, and India. Some variants are 
more transmissible and aggressive and may be more resistant to the current vac-
cines. The Delta variant has created serious concerns in several countries, especially 
in the USA where it became the dominant variant affecting adults, adolescents, and 
children, and causing spike in hospitalizations.
Figure 2. 
SARS-CoV-2.
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3.2 COVID-19 origin, mode of transmission, and action
The exact origin of SARS-CoV-2 has been subject of multiple debates and 
speculations (bats to humans through Huanan Seafood Market or release from 
a research laboratory, in Wuhan, Hubei Province, China). According to the 
former director of Centers for Disease Control and Prevention in the United 
States of America (USA), the virus most likely originated from the Wuhan 
research laboratory. The accidental or intentional release of the virus remains to 
be established.
Human-to-human transmission occurs mainly by direct contact or by drop-
lets spread by infected subjects through cough or sneeze. The virus can survive 
in the environment from a few hours to a few days, depending on the condi-
tions. The nose, mouth, and ocular mucosa are the major way of transmission 
(Figure 3).
The virus uses the host cell membrane protein receptors to enter and infect 
the cell. The most well-described cell membrane protein receptor is ACE2 (a 
zinc metalloprotease). First, the virus spike protein binds to ACE2. Then, there 
is an internalization of ACE2 with a subsequent reduction of cell surface ACE2 
enzymatic activity [14, 25, 29, 38, 55]. ACE2 is expressed in several organs 
including endocrine glands. It is abundant in the epithelia of the lung and 
intestine. Infected cells undergo apoptosis or necrosis and trigger inflammatory 
responses.
3.3 COVID-19 diagnostic tests
The Food and Drug Administration in the USA has approved two tests 
for diagnosing COVID-19 infection. The antigen test detects certain proteins 
in the virus. The polymerase chain reaction test detects genetic material of 
the virus. For both tests, the fluid sample is collected using a nasal swab 
(Figure 4).
Figure 3. 
Mode of transmission of SARS-CoV-2.
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3.4 COVID-19 consequences
Through infection and confinement/isolation, COVID-19 can influence life at 




COVID-19 has placed a significant burden upon healthcare worldwide. COVID-19 
can target different systems that express ACE2 (respiratory, cardiovascular, neurologi-
cal, gastrointestinal, endocrine, others). Although lung has been reported to be one 
of the most affected organs, the contribution of intestinal involvement to the clinical 
Figure 4. 
COVID-19 diagnostic tests use a nasal swab to collect fluid sample.
Figure 5. 
COVID-19 pandemic led to confinement/isolation.
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course of the disease and its treatment (through gut microbiota) has been highly specu-
lated [54]. All age groups may be affected. The disease is more severe in men [11, 12].
COVID-19 is associated with alterations in the host immunological status including 
an increase in pro-inflammatory cytokines. The surge of pro-inflammatory factors 
(“cytokine storm”) may cause host organ damage such as lung damage resulting in 
severe respiratory failure [8, 38]. Subjects infected with COVID-19 can be asymptom-
atic, have mild symptoms recovering within 1 to 2 weeks, or be severely affected (e.g., 
severe pneumonia and cardiogenic shock) with the ultimate risk of death. Common 
symptoms include fever, dry cough, dyspnea, arthralgia, myalgia, ageusia (loss of taste), 
and anosmia (loss of smell). COVID-19 symptoms can sometimes last several months. 
The damage to the lungs, heart, and brain can increase the risk of long-term symptoms 
(long haulers). Older subjects (> 65 years), black subjects, smokers, and subjects with 
immunodeficiency, cardiac and respiratory diseases, cancer, hypertension, diabetes, 
obesity, and dyslipidemia are considered high-risk populations [8–12, 14, 23–25, 31, 
33–37, 39]. Among COVID-19 mortality cases in Wuhan, China, the main associated 
comorbidities were hypertension (54%), diabetes (42%), and cardiac disease (19%) [9].
The public health recommendations during the COVID-19 pandemic 
resulted in social distancing and home confinement/isolation. More than 4 
billion people worldwide have experienced the COVID-19 mobility restriction. 
The life in home confinement and self-isolation for a long period has significant 
negative health consequences due to alterations in lifestyle (eating behavior and 
physical activity) and mental status, and the impact on pre-existing diseases  
[3, 21, 22, 31, 32, 40, 42, 56–58].
The changes in lifestyle (e.g., unhealthy diet and reduced physical activity) which 
affect both adults and children, can lead to weight gain (overweight or obesity). 
Sedentarism can cause a very rapid loss of muscle mass (up to 10% after 30 days) with 
degenerative changes of the neuromuscular system and reduced cardiorespiratory fit-
ness [21]. The confinement and isolation, especially if associated with unemployment 
and financial challenges, can negatively influence psychological health, and promote 
anxiety and depression, especially in women [3, 40, 57, 58]. It may also impact access 
to health care (e.g., medications, physicians, and hospital beds) for the management 
of pre-existing medical conditions (e.g., heart disease, cancer, and diabetes) [3].
Death can result from direct consequences of the viral infection, mental compli-
cations of confinement/isolation with the risk of suicide, or aggravation of pre-
existing diseases (Figure 6).
Figure 6. 
Death from COVID-19 pandemic affected millions of people worldwide.
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The extent of death from COVID-19 pandemic as of August 17, 2021 is reported 
in Table 2. African countries had a low mortality rate, at least at the beginning of 
the pandemic, that can be explained in part by the existence of less indoor activities 
(less exposure to the virus) and younger population.
Between March and October 2020, COVID-19 became the third leading 
cause of death in the USA (after heart disease and cancer) for persons aged 45 to 
84 years [7].
For several months and mainly due to political reasons, the magnitude and gravity 
of COVID-19 pandemic were not taken seriously in the USA at federal and some state 
levels. According to the former COVID-19 task force coordinator, with an appropriate 
management and policy, hundreds of thousands of lives could have been saved.
3.4.1.1.2 Endocrine and metabolic systems
Several endocrine and metabolic systems can be impacted by COVID-19 infec-
tion (Figure 7) [8–48]. Findings in this area are evolving and long-term effects of 
COVID-19 infection remain unknown.
Country Total Population Infected Subject Mortality
World Around  
7,900,000,000
At least  
207,173,000
At least  
4,362,000
USA Around  
333,000,000
At least  
36,385,000
At least  
615,000
Brazil Around  
214,000,000
At least  
20,350,000
At least  
568,000
India Around  
1,395,000,000
At least  
32,225,000
At least  
431,000
Mexico Around  
130,000,000
At least  
3,091,000
At least  
248,000
Peru Around  
33,000,000
At least  
2,132,000
At least  
197,000
Russia Around  
146,000,000
At least  
6,621,000
At least  
171,000
UK Around  
68,000,000
At least  
6,267,000
At least  
130,000
Italy Around  
60,000,000
At least  
4,440,000
At least  
128,000
Colombia Around  
51,000,000
At least  
4,864,000
At least  
123,000
Indonesia Around  
277,000,000
At least  
3,871,000
At least  
118,000
France Around  
65,000,000
At least  
6,311,000
At least  
111,000
Argentina Around  
46,000,000
At least  
5,080,000
At least  
108,000
Table 2. 
Extent of infection and death from COVID-19 pandemic in 12 countries ranked by descending order of death 
(WHO data, as of August 17, 2021).
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3.4.1.1.2.1 Hypothalamus, pituitary
The hypothalamus and pituitary tissues do express ACE2 and can theo-
retically be targeted by SARS-CoV-2. However, there are no solid data on 
 hypothalamic–pituitary dysfunction in subjects affected by COVID-19  
[8, 10, 12, 14].
In subjects with treated diabetes insipidus, the priority should be to avoid 
hyponatremia [8].
Management of pituitary tumors without signs of emergency (e.g., visual 
deterioration and apoplexy) can be differed for several months [16].
3.4.1.1.2.2 Thyroid
ACE2 receptors have been located in the thyroid. Data on thyroid involve-
ment during COVID-19 infection are relatively limited [8, 10, 12, 14, 17, 18]. 
Figure 7. 
Different endocrine systems can be impacted by COVID-19 infection.
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In severe cases of COVID-19, subjects may present with nonthyroidal illness 
syndrome [17]. Several cases of onset of subacute thyroiditis have been reported 
in subjects with COVID-19 infection [12, 14]. COVID-19 can be a precipitat-
ing factor for the initiation or relapse of Graves’ disease [8, 10]. In subjects 
receiving antithyroid drugs, because symptoms of agranulocytosis (a rare side 
effect of antithyroid drugs) can overlap with COVID-19, special attention is 
needed [12].
Diagnostic procedures and surgery for thyroid nodules can be postponed in most 
cases [8, 30]. The timing of surgery should be carefully decided for subjects with 
thyroid cancer [19, 30].
3.4.1.1.2.3 Parathyroid
Data on parathyroid disorders and COVID-19 infection are relatively rare. In 
case of hyperparathyroidism, surgery can be postponed without major clinical 
impact [20].
3.4.1.1.2.4 Adrenal
ACE2 is expressed in the adrenal gland. Impaired adrenocortical response has 
been reported in subjects with COVID-19 infection consistent with central adrenal 
insufficiency [15].
Subjects with Cushing’s disease or syndrome may be at higher risk of COVID-19 
infection since excess cortisol production has immunosuppressive effect [8, 12]. 
Medical treatment is recommended as first-line therapy for most of these subjects 
during the COVID-19 pandemic.
Adrenal insufficiency may create a potentially increased risk of acquiring 
COVID-19 infection as this condition is associated with impaired immunity. 
Subjects with adrenal insufficiency may be at higher risk of medical complica-
tions and increased mortality in case of COVID-19 infection. If COVID-19 
infection is suspected in subjects with adrenal insufficiency, a prompt increase 
in dose of the replacement therapy is indicated to avoid adrenal crisis [8, 10, 
12–14]. Subjects with known adrenal insufficiency and COVID-19 may require 
parenteral glucocorticoid treatment with careful monitoring of serum potassium 
[12, 13].
3.4.1.1.2.5 Pancreas
ACE2 is expressed in pancreas (both exocrine and endocrine pancreas). Physical 
inactivity leads to insulin resistance and systemic inflammation with subsequent 
metabolic consequences [21, 22]. COVID-19 infection, through multiple mecha-
nisms, may impair the function of the endocrine pancreas and promote or aggravate 
diabetes [10, 14, 23].
Chronic hyperglycemia in subjects with diabetes negatively impacts immune 
system and increases the risk of infection and morbidity/mortality due to COVID-19 
(Figure 8) [8–12, 14, 23–25]. It is important to maintain a good glycemic control in 
subjects with diabetes to reduce the risk of COVID-19 infection. In case of COVID-19 
infection, the outpatient plasma glucose goal is 72–144 mg/dL with a hemoglobin A1c 
goal less than 7%. Plasma glucose should be monitored at least twice a day. Insulin is 
the preferred treatment in hospitalized subjects with the use of continuous glucose 
monitoring [12].
Hot Topics in Endocrinology and Metabolism
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3.4.1.1.2.6 Testis
There is a high level of ACE2 expression in the testis (e.g., Sertoli cells, Leydig 
cells, and spermatogonia). COVID-19 infection may cause Sertoli cells, Leydig cells, 
and seminiferous tubules damages resulting in low serum testosterone levels and 
altered sperm quality [10, 12, 14, 26–28].
Men with COVID-19 are exposed to worse outcome than women, possibly due to 
sex differences in immune response [11, 12].
3.4.1.1.2.7 Ovary
ACE2 is expressed in the ovary. However, data on ovarian function and 
COVID-19 infection are limited [12, 14]. COVID-19 infection may disturb the 
female reproductive system and cause menstrual disorder, infertility, and fetal 
distress [29].
3.4.1.1.2.8 Adipose tissue
Adipose tissue expresses ACE2. The unhealthy diet and reduced physical activity 
promoted by confinement can lead to overweight or obesity, especially in high-
income countries/families [31, 32]. Low-income countries/families are exposed to 
food insecurity, malnutrition, and weight loss [31].
With higher adipose tissue mass, more receptors (ACE2) would be available 
for SARS-CoV-2, exposing subjects to COVID-19 [10]. Subjects with over-
weight/obesity may experience a more serious COVID-19 infection through 
several mechanisms (e.g., inflammation, impaired immunity, mechanical lung 
dysfunction, impact of comorbidities, and vitamin D deficiency) (Figure 9) 
[8–11, 14, 31, 33–37]. These subjects require weight reduction using the appro-
priate tools as indicated (e.g., diet, exercise, drug, medical device, and bariatric 
surgery) [36, 37, 59–62]. All precautions should be taken to avoid infection. 
Subjects with obesity and COVID-19 who require treatment in intensive care 
units present challenges in their management (e.g., difficulty for moving, for 
intubating, and for obtaining diagnostic imaging) [8].
Figure 8. 
COVID-19 pandemic can promote diabetes or be aggravated by diabetes.
11
Consequences of COVID-19 Pandemic Including Endocrine and Metabolic Impacts
DOI: http://dx.doi.org/10.5772/intechopen.100278
3.4.1.1.2.9 Lipids
The “cytokine storm” caused by COVID-19 produces an immune-mediated 
inflammatory dyslipidemia (e.g., decreased high-density lipoprotein cholesterol 
and low-density lipoprotein cholesterol, increased triglycerides, and increased 
lipoprotein oxidation) [38].
Dyslipidemia is one of the most common comorbidities in the general popula-
tion and in subjects with COVID-19. It can potentially increase the severity and 
mortality of COVID-19. This increased risk is more pronounced with older age, 
male gender, and presence of hypertension [39].
3.4.1.1.2.10 Nutrition (calories, macronutrients, electrolytes, vitamins) and exercise
During COVID-19 confinement, a healthy lifestyle is essential (Figure 10). An 
optimal nutrition (e.g., calories, macronutrients, electrolytes, and vitamins) is 
Figure 9. 
COVID-19 pandemic can promote overweight/obesity or be aggravated by overweight/obesity.
Figure 10. 
Healthy lifestyle is essential during COVID-19 pandemic.
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important, especially for boosting the immune system [21, 31, 33, 40–44, 47, 48]. 
It is recommended to reduce the daily energy intake by 15–25% with more energy 
during breakfast and less energy during lunch and dinner.
Diet should be balanced and contain fruits, vegetables, whole grains, low-fat 
dairy products, and olive oil, with adequate hydration. The consumption of sugar, 
saturated fat, and salt should be reduced. COVID-19 infected-subjects, especially 
those who are hospitalized, are at risk of malnutrition and need adequate nutri-
tional support [8].
Electrolytes and trace elements play an important role in the management of 
COVID-19. The severity of COVID-19 is associated with lower serum concentra-
tions of sodium, potassium, and calcium. It is important to assess the levels of 
electrolytes and trace elements throughout the course of the disease to establish 
appropriate corrective actions [45, 46].
Vitamins are important in the prevention of viral infection. Subjects at risk of or 
with respiratory viral infection should receive vitamin C and vitamin D. Particular 
attention should be paid to the treatment of subjects with hypovitaminosis D [8, 11, 12].
Safe handling of food, from production to consumption, is critical to reduce the 
risk of viral dissemination.
Daily exercise (e.g., low to medium-intensity exercise) is essential for prevent-
ing the negative impact of inactivity and improving health [21, 40].
COVID-19 has caused a major disruption in the management of subjects with 
endocrine and metabolic disorders. The services offered by healthcare systems must 
adapt rapidly. Outpatient management with remote advice and support services 
need to be organized [23, 30]. Routine in-person appointments are not recom-
mended in order to avoid crowds in waiting rooms [9]. Elective surgical procedures 
should be postponed when possible.
3.4.1.2 Financial consequences
Unemployment may cause financial challenges at the individual level and this 
can affect both physical and mental health (Figure 11) [31, 40]. Between February 
and May 2020, the number of unemployed Americans rose by more than 14 million.
Figure 11. 
Unemployment caused by COVID-19 pandemic may lead to individual financial challenges.
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3.4.1.3 Educational consequences
For the current generation of young people (children and adolescents), the 
disrupted education due to remote learning and lack of in-person classes during an 
extensive period of confinement and social distancing can negatively impact the 
quality of education and social skills (Figure 12).
3.4.2 Familial
During the enforced COVID-19 home confinement, there is an important 
decrease in the amount of familial/social activities (e.g., interactions with other 
individuals and entertainment), associated with a lower life satisfaction [63].
Confinement, isolation, and prolonged presence of parents and children 
expose to the risk of domestic violence. Children and their mothers are particularly 
vulnerable (Figure 13) [64].
Figure 12. 
The switch to remote learning during COVID-19 pandemic may impact the quality of education and social 
skills of the current generation of students.
Figure 13. 
The confinement following COVID-19 pandemic can promote domestic violence.
Hot Topics in Endocrinology and Metabolism
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3.4.3 Societal
COVID-19 pandemic led to a global economic recession [40]. According to a 
report released by the World Bank, in 2020, the world economy probably shrank by 
4.3% (equivalent of $3.9 trillion).
The financial burden of COVID-19 is mainly due to confinement and limita-
tion of social life. These restrictions lead to the limitation or closing of several 
businesses (with the subsequent increase of unemployment) affecting the income 
from agriculture, restaurant, hotel, store, airline, cruise, convention, concert, 
sport event, museum, movie, and theater (non-exhaustive list) and causing 
health issues, all contributing to a decrease in productivity and an increase in 
national debt.
Reducing social inequalities should become a priority for all countries to build 
resilience during the pandemic.
The pandemic also impacted medical research for hospitals and pharmaceutical 
companies by creating limitations in implementation and conduct of clinical trials 
in different countries, especially when in-person visits are necessary.
3.4.4 Environmental
The lockdown measures of COVID-19 pandemic caused a temporary reduction 
in global air pollution secondary to the decrease of anthropogenic activities (e.g., 
less circulating cars and flying planes) (Figure 14) [65–67].
Most polluted cities are located in Asia, especially in India, China, and Pakistan. 
Results of a study using satellite observations at the continental scale from January 
to May 2020 showed a substantial decrease in the concentrations of nitrogen diox-
ide (maximum reduction of 33% in East Asia), sulfur dioxide (maximum reduction 
of 41% in East Asia), and aerosol optical depth (maximum reduction of 37% in 
South Asia) during the lockdown period of 2020 compared to their averages for the 
baseline period (2015–2019) over all continents [65].
According to WHO, ambient air pollution was responsible for 4.2 million 
deaths worldwide in 2016 (mainly from respiratory infection, chronic obstruc-
tive  ulmonary disease, ischemic heart disease, stroke, and lung cancer). 
Any reduction in global air pollution, even for a short period of time, may 
Figure 14. 
The confinement due to COVID-19 pandemic temporarily reduced air pollution by decreasing the 
anthropogenic activities.
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theoretically have some health and financial benefits for humans. It can also be 
beneficial for  animals and plants.
3.5 COVID-19 prevention
3.5.1 General precautions
In many locations affected by COVID-19 infection, wearing mask, social 
distancing, and lockdown (with the possibility to work from home) became manda-
tory to prevent the expansion of the disease in the general population and the 
subsequent medical challenges for the healthcare system (Figure 15). In addition, 
subjects were encouraged to wear gloves when appropriate and do careful hand 
washing, especially before eating and drinking.
Politicization of wearing mask in some countries (e.g., USA) created medical 
challenges in the control of the pandemic.
3.5.2 Vaccination
Vaccination is the cheapest and most effective way to protect against COVID-19 
infection. Vaccine development is a lengthy process that usually takes 10–15 years, 
but development of COVID-19 vaccines followed a very fast pace mainly due to 
collaborative efforts of research institutions and active engagement of regulatory 
agencies.
Several vaccine candidates have been investigated by various companies in 
different countries using multiple vaccine platforms (e.g., live-attenuated, inacti-
vated, protein subunit, virus-like particle, replicating viral vector, non-replicating 
viral vector, DNA, and mRNA) [49–53]. Several vaccines were designed to use the 
SARS-CoV-2 spike protein or part of it as the immunogen. As of August 17, 2021, 21 
COVID-19 vaccines have been approved or authorized for emergency use by at least 
1 country. In the USA, Pfizer/BioNTech vaccine was first authorized for emergency 
use in subjects aged 16 years and older and later for adolescents aged 12 to 15 years. 
A partial list of the approved/authorized vaccines is reported in Table 3. Several 
clinical trials of additional COVID-19 vaccines are currently ongoing (44 trials in 
Phase 1, 59 trials in Phase 2, and 29 trials in Phase 3).
Figure 15. 
Wearing mask is a simple but very efficient way to protect against COVID-19 infection.
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As of August 17, 2021, the number of COVID-19 vaccine doses administered 
was more than 4,452,000,000. In most locations, the vaccination prioritized the 
healthcare workers, old subjects, and subjects with comorbidities. The mRNA vac-
cines need to be stored and transported at very low temperatures. This requirement 
may prevent effective distribution of these vaccines to areas with limited avail-
ability of specialized freezers. Viral spread will continue to cause significant health 
and economic issues until a sufficient number of subjects are vaccinated and herd 
immunity is achieved (Figure 16).
Figure 16. 
There is a need to vaccinate a minimum number of subjects worldwide against COVID-19 to reach herd 
immunity.
Company Type of Vaccine Number of Country  
Approval/Authorization
Oxford/AstraZeneca (UK) Non-replicating viral vector 121
Pfizer/BioNTech (USA/Germany) mRNA 97
Gamaleya (1) (Russia) Non-replicating viral vector 71
Moderna (USA) mRNA 68
Sinopharm Beijing (China) Inactivated 60
Janssen (USA) Non-replicating viral vector 59
Serum Institute of India (India) Non-replicating viral vector 45
Sinovac (China) Inactivated 39
Gamaleya (2) (Russia) Non-replicating viral vector 12
Bharat Biotech (India) Inactivated 9
CanSino (China) Non-replicating viral vector 8
Table 3. 
Top 11 COVID-19 vaccines approved/authorized by at least 1 country ranked by descending order of number of 
country approval/authorization (as of August 17, 2021).
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COVID-19 vaccines have a high efficacy (up to 95%) by providing significant 
protection against severe disease, hospitalization, and death. The duration 
of immunity after the first full vaccination is unknown. COVID-19 vaccine 
boosters are most likely necessary for all vaccinated subjects. In the USA, 
very recently, Pfizer/BioNTech and Moderna received authorization for an 
extra dose of vaccine in immunocompromised subjects. Some of the currently 
available vaccines provide partial to complete protection against SARS-CoV-2 
variants.
COVID-19 vaccines are overall safe and well tolerated. Subjects may develop 
minor side effects (e.g., swelling, redness, and pain at injection site, fever, 
headache, tiredness, muscle pain, chills, and nausea) lasting usually 1 or 2 days 
after the injection. In rare cases, subjects may develop anaphylaxis, myocarditis/
pericarditis, and thrombosis. Long-term side effects of COVID-19 vaccines 
are currently unknown. Limited data are available regarding vaccine safety in 
pregnancy.
There are a significant number of subjects with vaccine hesitancy 
for a variety of reasons including concerns about the unknown or undis-
closed side effects of the vaccines, absence of full vaccine approval, 
 ignorance, misinformation, selfishness, and political influence (mainly in 
the USA).
3.6 COVID-19 treatment
The standard management of COVID-19 infection is based on 
 supportive treatment with lung-protective ventilation and dexamethasone. 
Several drugs have also been investigated and used for the treatment of  
 COVID-19  infection. They include antiviral agents (e.g., remdesivir) and 
 monoclonal  antibodies (e.g., casirivimab + imdevimab and sotrovimab)  
(Figure 17) [68].
Figure 17. 
Several drugs to treat COVID-19 infection are currently used or under investigation.
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4. Life with COVID-19 pandemic
The COVID-19 pandemic may last several years and can cause dramatic changes 
in society, affecting our lives for generations to come. The precautions necessary 
to avoid infection or transmission of the virus may stay in effect for a long period. 
This has significant impact on life at different levels (e.g., family, profession, 
gathering, traveling, hand shaking, hugging, kissing, and love making). The new 
normal, even at a very personal level, may be very different and somehow odd 
(Figure 18).
5. Conclusions
COVID-19 pandemic became a global health and economic crisis of the 21st 
century. It represents one of the most profound medical, societal, and economic 
challenges in modern times.
The pandemic caused substantial morbidity and mortality. Almost all organs 
and biological systems are directly or indirectly impacted by COVID-19. The pres-
ence of diabetes and obesity contributes to a worse prognosis of COVID-19 infec-
tion due to impaired immune function.
Wearing mask, social distancing, home confinement, and isolation have been 
recommended and implemented in most countries to curb the spread of the out-
break. Mass quarantine leads to major health and social consequences.
Several efficient and safe vaccines are now available and have been used 
worldwide.
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Figure 18. 
The new normal after COVID-19 pandemic may look odd but necessary.
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